Page 4 of 9, showing 50 records out of 429 total, starting on record 151, ending on 200
| Publication |
Category |
Year |
|
450. Blais, Y., Gingras, S., Haagensen, D.E., Labrie, F., Simard, J. (1996). Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells. Mol. Cell. Endocrinol., 121: 11-18. |
Intracrinology |
1996 |
|
454. Poirier, D., Mérand, Y., Labrie, C., Labrie, F. (1996) D-Ring alkylamide derivatives of estradiol: Effect on ER-binding affinity and antiestrogenic activity. Bioorg. Med. Chem. Lett., 6: 2537-2542. |
Intracrinology |
1996 |
|
456. Auger, S., Mérand, Y., Pelletier, J.D., Poirier, D., Labrie, F. (1995) Synthesis and biological activities of thioether derivatives related to the antiestrogens tamoxifen and ICI 164384. J. Steroid Biochem. Mol. Biol., 52: 547-565. |
Intracrinology |
1995 |
|
457. Blais, Y., Sugimoto, K., Carrière, M.C., Haagensen, D.E., Labrie, F., Simard, J. (1995) Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1alpha on apolipoprotein D and GCDFP-15 expression in human breast cancer cells. Int. J. Cancer, 62: 732-737. |
Intracrinology |
1995 |
|
459. Labrie, F., Li, S., Labrie, C., Lévesque, C., Mérand, Y. (1995) Inhibitory effect of a steroidal antiestrogen (EM-170) on estrone-stimulated growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat. Breast Cancer Res. Treat., 33: 237-244. |
Intracrinology |
1995 |
|
460. Li, S., Lévesque, C., Geng, C.S., Yan, X., Labrie, F. (1995) Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat. Breast Cancer Res. Treat., 34: 147-159. |
Intracrinology |
1995 |
|
465. Pelletier, J.D., Labrie, F., Poirier, D. (1994) N-butyl, N-methyl, 11-3',17'β-dihydroxy-1'3'5'(10') estratrien-16'α-yl)-9-(R/S)bromo undecanamide: synthesis and 17β-HSD inhibiting activity, estrogenic activity and antiestrogenic activity. Steroids, 59: 536-547. |
Intracrinology |
1994 |
|
466. Poirier, D., Auger, S., Mérand, Y., Simard, J., Labrie, F. (1994) Synthesis and antiestrogenic activity of diaryl thioether derivatives. J. Med. Chem., 37: 1115-1125. |
Intracrinology |
1994 |
|
468. Couture, P., Thériault, C., Simard, J., Labrie, F. (1993) Androgen receptor-mediated stimulation of 17β-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Endocrinology, 132: 179-185. |
Intracrinology |
1993 |
|
470. Li, S., Yan, X., Bélanger, A., Labrie, F. (1993) Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(?)anthracene (DMBA) in the rat. Breast Cancer Res. Treat., 29: 203-217. |
Intracrinology |
1993 |
|
473. Labrie, C., Martel, C., Dufour, J.M., Lévesque, C., Mérand, Y., Labrie, F. (1992) Novel compounds inhibit estrogen formation and action. Cancer Res., 52: 610-615. |
Intracrinology |
1992 |
|
474. Labrie, F., Simard, J., de Launoit, Y., Poulin, R., Thériault, C., Dumont, M., Dauvois, S., Martel, C., Li, S.; (1992) Androgens and breast cancer. Cancer Detect. Prev., 16: 31-38. |
Intracrinology |
1992 |
|
476. Roy, R., Dauvois, S., Labrie, F., Bélanger, A. (1992) Estrogen-stimulated glucuronidation of dihydrotestosterone in MCF-7 human breast cancer cells. J. Steroid Biochem. Mol. Biol., 41: 579-582. |
Intracrinology |
1992 |
|
477. Simard, J., de Launoit, Y., Haagensen, D.E., Labrie, F. (1992) Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein D messenger RNA levels and secretion in human breast cancer cells. Endocrinology, 130: 1115-1121. |
Intracrinology |
1992 |
|
478. Dauvois, S., Geng, C.S., Lévesque, C., Mérand, Y., Labrie, F. (1991) Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice. Cancer Res., 51: 3131-3135. |
Intracrinology |
1991 |
|
479. de Launoit, Y., Dauvois, S., Dufour, M., Simard, J., Labrie, F. (1991) Inhibition of cell cycle kinetics and proliferation by the androgen 5α-dihydrotestosterone and antiestrogen N,n-butyl-N-methyl-11-[16'a-chloro-3',17β-dihydroxy-estra-1',3',5'-(10')triene-7'a-yl] undecanamide in human breast cancer ZR-75-1 cells. Cancer Res., 51: 2797-2802. |
Intracrinology |
1991 |
|
481. Lévesque, C., Mérand, Y., Dufour, J.M., Labrie, C., Labrie, F. (1991) Synthesis and biological activity of new halo-steroidal antiestrogens. J. Med. Chem., 34: 1624-1630. |
Intracrinology |
1991 |
|
485. Bélanger, A., Caron, S., Labrie, F., Naldoni, C., Dogliotti, L., Angeli, A. (1990) Levels of eighteen non-conjugated and conjugated steroids in human breast cyst fluid: Relationships with cyst type. Eur J Cancer, 26: 277-281. |
Intracrinology |
1990 |
|
487. Dauvois, S., Labrie, F. (1990) Effect of adrenal estrogens on the growth of dimethylbenz(a)antracene-induced mammary carcinoma in the rat. In: Bradlow, H., Castagnetta, L., d'Aquino, S. et Labrie, F., eds. Steroid Formation, Degradation and Action in Peripheral Tissues, Normal and Neoplastic Tissues. Ann. New York Acad. Sci. pp 416-418. |
Intracrinology |
1990 |
|
488. Dauvois, S., Li, S., Labrie, F. (1990) Antagonism between androgens and estrogens on the growth of mammary carcinoma in vivo. In: Bradlow, H., Castagnetta, L., d'Aquino, S. et Labrie, F., eds. Steroid Formation, Degradation and Action in Normal, Neoplasic and Peripheral Tissues. Ann. New York Acad. Sci. pp 413-415. |
Intracrinology |
1990 |
|
489. Dauvois, S., Simard, J., Dumont, M., Haagensen, D.E., Labrie, F. (1990) Opposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells. Mol. Cell. Endocrinol. 73: 171-178. |
Intracrinology |
1990 |
|
491. Labrie, F., Poulin, R., Simard, J., Zhao, H., Labrie, C., Dauvois, S., Dumont, M., Hatton, A.C., Poirier, D., Mérand, Y. (1990) Interactions between estrogens, androgens, progestins and glucocorticoids in ZR-75-1 human breast cancer cells. in: Bradlow, H., Castagnetta, L., d'Aquino, S. et Labrie, F. eds. Steroid Formation, Degradation and Action in Peripheral Tissues, Normal and Neoplastic Tissues. Ann. N.Y. Acad. Sci. 595: 130-148. |
Intracrinology |
1990 |
|
492. Labrie, F., Simard, J., Poulin, R., Hatton, A.C., Labrie, C., Dauvois, S., Zhao, H., Petitclerc, L., Couet, J., Dumont, M., Haagensen D.E. (1990) Potent antagonism between estrogens and androgens on GCDFP-15 expression and cell growth in the ZR-75-1 human breast cancer cells. In: Angeli, A., Bradlow, H., Chasalow, F.I. et Dogliotti, L. eds. Workshop on Biochemistry of Breast Cyst Fluid and Cancer Risk. Ann. N.Y. Acad. Sci. 586: 174-187. |
Intracrinology |
1990 |
|
493. Laquerre, S., Poulin, R., Labrie, F., Chafouleas, J.G. (1990) Identification of a 51-kilodalton calmodulin binding protein that changes during estrogen-stimulated cell growth. Biochem. Cell Biol., 68: 863-869. |
Intracrinology |
1990 |
|
495. Marchetti, B., Labrie, F. (1990) Hormonal regulation of beta-adrenergic receptors in the rat mammary gland during the estrous cycle and lactation: role of sex steroids and prolactin. Endocrinology, 126: 575-581. |
Intracrinology |
1990 |
|
496. Poirier, D., Poulin, R., Mérand, Y., Thériault, C., Labrie, F. (1990) High level of esterification of steroids to long-chain fatty acids in ZR-75-1 human breast cancer cells. In: Bradlow, H., Castagnetta, L., d'Aquino, S. et Labrie, F. eds. Steroid Formation, Degradation and Action in Peripheral Tissues, Normal and Neoplastic Tissues. Ann. New York Acad. Sci. pp 422-424. |
Intracrinology |
1990 |
|
498. Poulin, R., Poirier, D., Thériault, C., Couture, J., Bélanger, A., Labrie, F. (1990) Wide spectrum of steroids serving as substrates for the formation of lipoidal derivatives in ZR-75-1 human breast cancer cells. J. Steroid Biochem., 35: 237-247. |
Intracrinology |
1990 |
|
499. Simard, J., Dauvois, S., Haagensen, D.E., Lévesque, C., Mérand, Y., Labrie, F. (1990) Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer. Endocrinology, 126: 3223-3231. |
Intracrinology |
1990 |
|
500. Thériault, C., Poulin, R., Tremblay, S., Poirier, D., Labrie, F. (1990) Hormonal regulation of estradiol 17beta-hydroxysteroid dehydrogenase activity in the ZR-75-1 human breast cancer cell line. In: Bradlow, H., Castagnetta, L., d'Aquino, S. et Labrie, F. eds. Steroid Formation, Degradation and Action in Peripheral, Normal and Neoplastic Tissues. Ann. New York Acad. Sci. pp 419-421. |
Intracrinology |
1990 |
|
502. Dauvois, S., Li, S., Martel, C., Labrie, F. (1989) Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat. Breast Cancer Res. Treat., 14: 299-306. |
Intracrinology |
1989 |
|
504. Dumont, M., Dauvois, S., Simard, J., Garcia, T., Schachter, B., Labrie, F. (1989) Antagonism between estrogens and androgens on GCDFP-15 gene expression in ZR-75-1 cells and correlation between GCDFP-15 and estrogen as well as progesterone receptor expression in human breast cancer. J. Steroid Biochem., 34: 397-402. |
Intracrinology |
1989 |
|
506. Poulin, R., Baker, D., Poirier, D., Labrie, F. (1989) Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Breast Cancer Res. Treat., 13: 161-172. |
Intracrinology |
1989 |
|
507. Poulin, R., Dufour, J.-M., Labrie, F. (1989) Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: antagonism by insulin. Breast Cancer Res. Treat., 13: 265-276. |
Intracrinology |
1989 |
|
508. Poulin, R., Mérand, Y., Poirier, D., Lévesque, C., Dufour, J.M., Labrie, F. (1989) Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen and ICI 164384, a new steroidal derivative, in ZR-75-1 human breast cancer cells. Breast Cancer Res. Treat., 14: 65-76. |
Intracrinology |
1989 |
|
509. Poulin, R., Poirier, D., Mérand, Y., Thériault, C., Bélanger, A., Labrie, F. (1989) Extensive esterification of adrenal C19-?5 sex steroids to long-chain fatty acids in the ZR-75-1 human breast cancer cell line. J. Biol. Chem., 264: 9335-9343. |
Intracrinology |
1989 |
|
510. Poulin, R., Simard, J., Labrie, C., Petitclerc, L., Dumont, M., Lagacé, L., Labrie, F. (1989) Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line. Endocrinology, 125: 392-399. |
Intracrinology |
1989 |
|
511. Simard, J., Hatton, A.-C., Labrie, C., Dauvois, S., Zhao, H., Haagensen, D.E., Labrie, F. (1989) Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells. Mol. Endocrinol., 3: 694-702. |
Intracrinology |
1989 |
|
521. Poulin, R., Baker, D., Labrie, F. (1988) Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res. Treat., 12: 213-225. |
Intracrinology |
1988 |
|
522. Poulin, R., Mérand, Y., Labrie, F. (1988) Antiestrogenic properties of a 7?-alkylated derivative of 17?-estradiol in ZR-75-1 human breast cancer, in: Genazzani, A.R., Petraglia, F., Volpe, A. et Facchinetti, F., eds: Recent Research in Gynecological Endocrinology, Parthenon Publishing Group, pp 631-634. |
Intracrinology |
1988 |
|
523. Spinola, P.G., Marchetti, B., Mérand, Y., Labrie, F. (1988) Effects of the aromatase inhibitor 4-hydroxyandrostenedione and antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors. Breast Cancer Res. Treat., 12: 287-296. |
Intracrinology |
1988 |
|
556. Labrie, F., Cusan, L., Gomez, J.L., Martel, C., Bérubé, R., Bélanger, P., Chaussade, V., Deloche, C., Leclaire, J. (2008) Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA. J Steroid Biochem Mol Biol, 110: 1-9. |
Intracrinology |
2008 |
|
559. Labrie, F., Bélanger, A., Bélanger, P., Bérubé, R., Martel, C., Cusan, L., Gomez, J., Candas, B., Chaussade, V., Castiel, I., Deloche, C., Leclaire, J. (2007) Metabolism of DHEA in postmenopausal women following percutaneous administration., 103: 178-88. |
Intracrinology |
2007 |
|
560. Labrie, F., Bélanger, A., Labrie, C., Candas, B., Cusan, L., Gomez, J.L. (2007) Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women. J Steroid Biochem Mol Biol, 107: 57-69. |
Intracrinology |
2007 |
|
561. Liu, H., Bellemare, V., Labrie, F., Luu-The, V. (2007) Molecular characterization of the cynomolgus monkey Macaca fascicularis steroidogenic enzymes belonging to the aldo-keto reductase family. J Steroid Biochem Mol Biol, 104: 75-80. |
Intracrinology |
2007 |
|
564. Swanson, C., Lorentzon, M., Vandenput, L., Labrie, F., Rane, A., Jakobsson, J., Chouinard, S., Bélanger, A., Ohlsson, C. (2007) Sex steroid levels and cortical bone size in young men are associated with a uridine diphosphate glucuronosyltransferase 2B7 polymorphism (H268Y). J Clin Endocrinol Metab, 92: 3697-704. |
Intracrinology |
2007 |
|
568. Bellemare, V., Labrie, F., Luu-The, V. (2006) Isolation and characterization of a cDNA encoding mouse 3beta-hydroxysteroid dehydrogenase an androgen-inactivating enzyme selectively expressed in female tissues. J Steroid Biochem Mol Biol, 98: 18-24. |
Intracrinology |
2006 |
|
569. Chouinard, S., Tessier, M., Vernouillet, G., Gauthier, S., Labrie, F., Barbier, O., Bélanger, A. (2006) Inactivation of the pure antiestrogen Fulvestrant and other synthetic estrogen molecules by UGT1A enzymes expressed in the breast tissue. Mol Pharmacol, 69: 908-20. |
Intracrinology |
2006 |
|
570. Compère, V., Ouellet, J., Luu-The, V., Dureuil, B., Tonon, M.C., Vaudry, H., Labrie, F., Pelletier, G. (2006) Role of androgens and glucocorticoids in the regulation of diazepam-binding inhibitor mRNA levels in male mouse hypothalamus. Brain Res. 1119: 50-7. |
Intracrinology |
2006 |
|
571. Eriksson, A.L., Lorentzon, M., Mellstrom, D., Vandenput, L., Swanson, C., andersson, N., Hammond, G.L., Jakobsson, J., Rane, A., Orwoll, E.S., Ljunggren, O., Johnell, O., Labrie, F., Windahl, S.H., Ohlsson, C. (2006) SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density. J Clin Endocrinol Metab, 91: 5029-37. |
Intracrinology |
2006 |
|
572. Faucher, F., Pereira de Jésus-Trans, K., Cantin, L., Luu-The, V., Labrie, F., Breton, R. (2006) Crystal structures of mouse 17beta-hydroxysteroid dehydrogenase (Apoenzyme and enzyme-NADP(H) binary complex): Identification of molecular determinants responsible for the unique 17beta-reductive activity of this enzyme. J.Mol. Biol., 364: 747-763. |
Intracrinology |
2006 |